本报讯(记者袁传玺)天眼查工商信息显示，近日，贵州茅台（600519）生物科技研发有限责任公司成 立，注册资本10亿元，经营范围含工程和技术研究和试验发展、生物化工产品技术研发、发酵过程优化 技术研发、工业酶制剂研发等。股东信息显示，该公司由中国贵州茅台酒厂(集团)有限责任公司、贵州 茅台共同持股。 ...

（原标题：贵州茅台生物科技研发公司成立，注册资本10亿） 企查查APP显示，近日，贵州茅台生物科技研发有限责任公司成立，法定代表人为杨帆，注册资本10亿人民币，经营范围含生物化工产品技术研 发、发酵过程优化技术研发、工业酶制剂研发、细胞技术研发和应用、生物农药技术研发等。企查查股权穿透显示，该公司由中国贵州茅台酒厂 （集团）有限责任公司、贵州茅台（600519）共同持股。 ...

Core Viewpoint - Qingye Wang Biotechnology (Yancheng) Co., Ltd. has been established with a registered capital of 500,000 RMB, focusing on various biotechnology and agricultural services [1] Company Overview - The company is legally represented by Zhu Haixia and has a registered capital of 500,000 RMB [1] - The business scope includes technology services, development, consulting, and transfer related to biotechnology and agricultural products [1] Research and Development Focus - The company specializes in the research and development of fermentation process optimization technology, industrial enzyme preparations, and biological chemical products [1] - It also focuses on the development of biological feed, composite microbial fertilizers, and biological organic fertilizers [1] Environmental and Agricultural Services - The company is involved in the research and development of technologies for the harmless utilization of agricultural and forestry waste, as well as soil pollution remediation and prevention services [1] - It provides services for the prevention of agricultural non-point source pollution and heavy metal contamination [1] Sales and Marketing - The company engages in the sale of fertilizers, chemical fertilizers, feed additives, food additives, and pre-packaged food [1] - It also conducts internet sales, vegetable and fruit planting, and operates independently within the scope of its business license [1]

Core Insights - Shanghai Taozhiyuan Biotechnology Co., Ltd. has been established with a registered capital of 100,000 RMB [1] - The company is engaged in various activities including technology services, development, consulting, and sales related to biological feed and fertilizers [1] Company Overview - The legal representative of the company is Zhang Jian [1] - The business scope includes general projects such as technology transfer, biological feed research and development, and sales of feed additives and raw materials [1] - The company also focuses on the research and development of biological organic fertilizers and compound microbial fertilizers [1] Industry Implications - The establishment of the company indicates a growing interest in biotechnology and agricultural sectors, particularly in feed and fertilizer solutions [1] - The inclusion of internet sales in the business scope suggests a potential for e-commerce integration in the agricultural industry [1]

Group 1 - The company completed the acquisition of 52.0006% equity in Shan'en Kang Biotechnology (Suzhou) Co., Ltd. on April 7, 2024 [2] - Following the acquisition, shareholder Yu Xueping will transfer 1% of the equity held on behalf of Ling Zhenjing to Ling Zhenjing, as per the agreement [2] - The name of the shareholder "Dongtai Liyue Enterprise Management Center (Limited Partnership)" has been changed to "Shanghai Shanhe Liyue Enterprise Management Center (Limited Partnership)" [2] Group 2 - Shan'en Kang has completed the industrial and commercial change registration and obtained a new business license from the Kunshan Data Bureau [2] - The registered capital of Shan'en Kang is 87.292808 million yuan, and it was established on September 29, 2016 [2] - The business scope includes technology consulting, food production, sales of household appliances, and import-export business [2]

Core Viewpoint - Jiangsu Zeyu Biotechnology Co., Ltd. has been established with a registered capital of 10 million yuan, focusing on various advanced biotechnologies and medical research [1] Company Summary - The legal representative of Jiangsu Zeyu Biotechnology Co., Ltd. is Zhang Jian [1] - The company's business scope includes cell technology research and application, human stem cell technology development and application, medical research and experimental development, natural science research and experimental development, and human genetic diagnosis and treatment technology development [1] - Zeyu Intelligent (301179) is among the shareholders of Jiangsu Zeyu Biotechnology Co., Ltd. [1]